Anjing Chen

Employment

• Qilu Hospital of Shandong University Professor
  2020 - Present
• Shandong University Postdoc
  2018 - 2022

Education

• Shandong University Doctor
  2008 - 2013

Projects & Funding

Projects & funding information is unavailable.

Publications (59)

• Targeting the molecular chaperone CCT2 inhibits GBM progression by influencing KRAS stability
  Cancer Letters 2024 DOI: 10.1016/J.CANLET.2024.216844
  +Save
• Cuproptosis: Mechanism, role, and advances in urological malignancies
  Medicinal Research Reviews 2024 DOI: 10.1002/MED.22025
  +Save
• Editorial: The advances in proteomics and targeted therapy of malignant brain tumours
  Frontiers in Oncology 2023 DOI: 10.3389/fonc.2023.1195847
  +Save
• BCL2L13 promotes mitophagy through DNM1L-mediated mitochondrial fission in glioblastoma
  Cell Death and Disease 2023 DOI: 10.1038/S41419-023-06112-4
  +Save
• Valtrate, an iridoid compound in Valeriana, elicits anti-glioblastoma activity through inhibition of the PDGFRA/MEK/ERK signaling pathway
  Journal of Translational Medicine 2023 DOI: 10.1186/S12967-023-03984-0
  +Save
• Comprehensive analysis of PSMD family members and validation of PSMD9 as a potential therapeutic target in human glioblastoma
  CNS Neuroscience & Therapeutics 2023 DOI: 10.1111/cns.14366
  +Save
• Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme
  Frontiers in Immunology 2022 DOI: 10.3389/fimmu.2022.840785
  +Save
• Identification of BST2 Contributing to the Development of Glioblastoma Based on Bioinformatics Analysis
  Frontiers in Genetics 2022 DOI: 10.3389/FGENE.2022.890174
  +Save
• Knockdown of NUSAP1 inhibits cell proliferation and invasion through downregulation of TOP2A in human glioblastoma
  Cell Cycle 2022 DOI: 10.1080/15384101.2022.2074199
  +Save
• Prodigiosin inhibits the proliferation of glioblastoma by regulating the KIAA1524/PP2A signaling pathway
  Scientific Reports 2022 DOI: 10.1038/S41598-022-23186-W
  +Save